@incollection{, 291F60B60E9A5B9CA9A84E884E18E96F , author={{}}, journal={{}}, journal={{}}, address={Cambridge, United States}, publisher={Great Britain Journals Press Organisation} } @incollection{b0, , title={{Profound but reversible myocardial depression in patients with septic shock}} , author={{ MMParker } and { JHShelhamer } and { SLBacharach } and { MVGreen } and { CHFredericket } and { TM }} , journal={{Ann Intern Med}} 100 4 , year={1984} } @incollection{b1, , title={{Sepsis associated myocardial dysfunction: Diagnostic and prognostic impact of Cardiac Troponins and Natriuretic Peptides}} , author={{ MMaeder } and { TFehr } and { HRickli } and { PAmmann }} , journal={{Chest}} 129 5 , year={2006} } @incollection{b2, , title={{Hemodynamic Instability in Sepsis. Bedside Assessment by Doppler Echocardiography}} , author={{ AVieillard-Baron } and { SPrin } and { KChergui } and { ODubourg } and { FJardin }} , journal={{Am J Respir Crit Care Med}} 168 11 , year={2003} } @incollection{b3, , title={{Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment}} , author={{ EAntonucci } and { EFiaccadori } and { KDonadello } and { FSTaccone } and { FFranchi } and { SScolletta }} , journal={{J Crit Care}} 29 , year={2014} } @incollection{b4, , title={{Actual incidence of global left ventricular hypokinesia in adult septic shock}} , author={{ AVieillard-Baron } and { VCaille } and { CCharron } and { GBelliard } and { BPage }} , journal={{Crit Care Med}} 36 , year={2008} } @incollection{b5, , title={{Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock}} , author={{ FJardin } and { TFourme } and { BPage } and { YLoubières } and { AVieillard-Baron } and { ABeauchet }} , journal={{Chest}} 116 5 , year={1999} } @incollection{b6, , title={{A circulating myocardial depressant substance in humans with septic shock: septic shock patients with reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance}} , author={{ JEParrillo } and { CBurch } and { JHShelhamer } and { MMParker } and { CNatanson } and { WSchuette }} , journal={{J Clin Invest}} 76 , year={1985} } @incollection{b7, , title={{IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma}} , author={{ DLMaass } and { JWhite } and { JWHorton }} , journal={{Shock}} 18 4 , year={2002} } @incollection{b8, , title={{New Approaches to Modifying Inotropy in Sepsis-Induced Myocardial Dysfunction}} , author={{ KRWalley }} , journal={{Critical Care Medicine}} 45 4 , year={2017} } @incollection{b9, , title={{Cardiac ICAM-1 mediates leukocytedependent decreased ventricular contractility in endotoxemic mice}} , author={{ EYDavani } and { JHBoyd } and { DRDorscheid }} , journal={{Cardiovasc Res}} 72 , year={2006} } @incollection{b10, , title={{Myocardial dysfunction in sepsis: mechanisms and therapeutic implications}} , author={{ SPrice } and { PBAnning } and { JAMitchell } and { TWEvans }} , journal={{European Heart Journal}} 20 , year={1999} } @incollection{b11, , title={{The role of nitric oxide signaling in sepsis-induced myocardial dysfunction}} , author={{ PSteendijk }} , journal={{Crit Care Med}} 34 1 , year={2006} } @incollection{b12, , title={{The coronary circulation in human septic shock}} , author={{ RECunnion } and { GLSchaer } and { MMParker } and { CNatanson } and { JEParrillo }} , journal={{Circulation}} 73 4 , year={1986} } @incollection{b13, , title={{Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock}} , journal={{Critical Care Medicine}} 49 11 , year={2021} } @incollection{b14, , title={{Increase of myocardial inhibitory Gproteins in catecholamine refractory septic shock or in septic multiorgan failure}} , author={{ MBöhm } and { RKirchmayr } and { PGierschik } and { EErdmann }} , journal={{Am J Med}} 98 , year={1995} } @incollection{b15, , title={{Pharmacologic issues in the management of septic shock}} , author={{ NJindal } and { SMHollenberg } and { RPDellinger }} , journal={{Crit Care Clin}} 16 , year={2000} } @incollection{b16, , title={{Myocardial dysfunction in the patient with sepsis}} , author={{ SKrishnagopalan } and { AKumar } and { JEParrillo } and { AKumar }} , journal={{Current opinion in critical care}} 8 5 , year={2002} } @book{b17, , title={{Lack of beneficial effects of milrinone in severe septic shock Circ Shock}} , author={{ SLindgren } and { PAlmqvist } and { DArvidsson } and { AMontgomery } and { KEAndersson } and { UHaglund }} , year={1990} 31 } @incollection{b18, , title={{Association between inotrope treatment and 90-day mortality in patients with septic shock}} , author={{ EWilkman } and { KMKaukonen } and { VPettila } and { AKuitunen } and { MVarpula }} , journal={{Acta Anaesthesiol Scand}} 57 4 , year={2013} } @incollection{b19, , title={{Milrinone role in treatment of septic shock}} , author={{ VTomicic } and { LZouein } and { JEspinoza } and { SUgarte }} , journal={{London Journal of Medical and Health Research}} 20 1 154 , year={2015} , note={Crit Care} } @incollection{b20, , title={{The effects of milrinone on hemodynamics in an experimental septic shock model}} , author={{ J-MLiet } and { JacquelineCOrsonneau } and { JL } and { Gras-LeguenCh } and { GPotel } and { J-ChRozé }} , journal={{Pediatr Crit Care Med}} 6 , year={2005} } @incollection{b21, , title={{Diminished Responsiveness to Dobutamine as an Inotrope in Mice with Cecal Ligation and Puncture Induced Sepsis: Attribution to Phosphodiesterase 4 Up-regulation}} , author={{ MSakai } and { TSuzuki } and { KTomita } and { SYamashita } and { SPalikhe } and { KHattori }} , journal={{Am J Physiol Heart Circ Physiol}} 312 6 , year={2017} } @incollection{b22, , title={{Combination Therapy with Milrinone and Esmolol for Heart Protection in Patients with Severe Sepsis: A Prospective Randomized Trial}} , author={{ ZWang } and { QWu } and { XNie } and { JGuo } and { CYang }} , journal={{Clin Drug Investig}} 35 11 , year={2015} } @incollection{b23, , title={{Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression}} , author={{ CASchmittinger } and { MWDünser } and { MHaller } and { HUlmer } and { GLuckner } and { CTorgersen }} , journal={{Critical Care}} 12 99 , year={2008} } @incollection{b24, , title={{}} , author={{ VTomicic } and { JGerrero } and { Endotelio } and { Sepsis }} , journal={{Med Intensiva}} 29 3 , year={2005} } @incollection{b25, , title={{Pharmacotherapy Update on the Use of Vasopressors and Inotropes in the Intensive Care Unit}} , author={{ JCJentzer } and { JCCoons } and { CBLink } and { MSchmidhofer }} , journal={{Journal of Cardiovascular Pharmacology and Therapeutics}} 20 3 , year={2015} } @incollection{b26, , title={{The use of more tan one inotrope in acute heart failure is associated with increased mortality: a multicentre observational study}} , author={{ JOssinen } and { VPHarjola } and { KSiirila-Waris } and { JLassus } and { JMelin } and { KPeuhkurinen }} , journal={{Acute Cardiac Care}} 10 4 , year={2008} } @incollection{b27, , title={{Milrinone and dobutamine in severe heart failure: Differing hemodynamic effects and individual patient responsiveness}} , author={{ WSColucci } and { RFWright } and { BEJaski } and { MAFifer } and { EBraunwald }} , journal={{Circulation}} 73 3 , year={1986} } @incollection{b28, , title={{Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition}} , author={{ WSColucci } and { ARDenniss } and { GFLeatherman } and { RJQuigg } and { DFGauthier }} , journal={{J Clin Invest}} 81 4 , year={1988} } @incollection{b29, , title={{Additive effects of milrinone and dobutamine in severe heart failure}} , author={{ AMeissner } and { GHerrmann } and { LGerdesmeyer } and { RSimon }} , journal={{Z Kardiol}} 81 5 , year={1992} } @incollection{b30, , title={{Left ventricular systolic and diastolic function in septic shock}} , author={{ JPoelaert } and { CDeclerck } and { DVogelaers } and { FColardyn } and { CAVisser }} , journal={{Intensive Care Med}} 23 5 , year={1997} } @incollection{b31, , title={{Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide treated rabbits: Comparison with dobutamine and milrinone}} , author={{ DBarraud } and { VFaivre } and { TDamy } and { SWelschbillig } and { EGayat } and { CHeymes }} , journal={{Crit Care Med}} 35 , year={2007} } @incollection{b32, , title={{Pharmacologic approach in patients with heart failure}} , author={{ SAGeraci }} , booktitle={{The Pharmacologic Approach to the Critically ill Patient}} , editor={ BChernow } , publisher={Williams and Wilkins} , year={1994} } @incollection{b33, , title={{Effect of levosimendán on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials}} , author={{ WChang } and { JFXie } and { JYXu } and { YYang }} 10.1136/bmjopen-2017-019338 , journal={{BMJ Open}} 8 3 19338 , year={2018} } @incollection{b34, , title={{Levosimendan does not reduce the mortality of critically ill adult patients with sepsis and septic shock: A meta analysis}} , author={{ FFeng } and { YChen } and { MLi } and { JJYuan } and { XNChang } and { CMDong }} , journal={{Chin Med J (Engl)}} 132 10 , year={2019 May 20} } @incollection{b35, , title={{Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial}} , author={{ JBMeng } and { MHHu } and { ZZLai } and { JICl } and { XJXu } and { GZhang } and { STian }} , journal={{Med Sci Monit}} 22 , year={2016 May 3} } @incollection{b36, , title={{Evolution of haemodynamics and outcome of fluid-refractory septic shock in children}} , author={{ ADeep } and { CDGoonasekera } and { YWang } and { JBrierley }} , journal={{Intensive Care Med}} 39 , year={2013} } @incollection{b37, , title={{}} , journal={{London Journal of Medical and Health Research}} }